LeMaitre Vascular Inc
NASDAQ:LMAT

Watchlist Manager
LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc
NASDAQ:LMAT
Watchlist
Price: 86.07 USD 3.09% Market Closed
Market Cap: 1.9B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+21%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

LMAT Price Targets Summary
LeMaitre Vascular Inc

Wall Street analysts forecast LMAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LMAT is 107.74 USD with a low forecast of 90.9 USD and a high forecast of 126 USD.

LMAT Lowest Forecast
Wall Street Target
90.9 USD
6% Upside
LMAT Average Forecast
Wall Street Target
107.74 USD
25% Upside
LMAT Highest Forecast
Wall Street Target
126 USD
46% Upside
Lowest
Price Target
90.9 USD
6% Upside
Average
Price Target
107.74 USD
25% Upside
Highest
Price Target
126 USD
46% Upside
LeMaitre Vascular Inc Competitors:
Price Targets
IRTC
iRhythm Technologies Inc
27% Upside
R
REG1V
Revenio Group Oyj
21% Upside
S
STXS
Stereotaxis Inc
144% Upside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
46% Upside
IRTC
iRhythm Technologies Inc
27% Upside
R
REG1V
Revenio Group Oyj
21% Upside
S
STXS
Stereotaxis Inc
144% Upside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
46% Upside

Revenue
Forecast

Revenue Estimate
LeMaitre Vascular Inc

For the last 8 years the compound annual growth rate for LeMaitre Vascular Inc's revenue is 12%. The projected CAGR for the next 4 years is 11%.

12%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
LeMaitre Vascular Inc

For the last 8 years the compound annual growth rate for LeMaitre Vascular Inc's operating income is 16%. The projected CAGR for the next 4 years is 20%.

16%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
LeMaitre Vascular Inc

For the last 8 years the compound annual growth rate for LeMaitre Vascular Inc's net income is 18%. The projected CAGR for the next 4 years is 19%.

18%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

See Also

Summary
LMAT intrinsic value, competitors valuation, and company profile.
DCF Valuation
LMAT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LMAT stock valuation using valuation multiples.
Wall Street Estimates
LMAT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LMAT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LMAT's stock price target?
Price Target
107.74 USD

According to Wall Street analysts, the average 1-year price target for LMAT is 107.74 USD with a low forecast of 90.9 USD and a high forecast of 126 USD.

What is LeMaitre Vascular Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for LeMaitre Vascular Inc's revenue is 12%. The projected CAGR for the next 4 years is 11%.

What is LeMaitre Vascular Inc's Operating Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for LeMaitre Vascular Inc's operating income is 16%. The projected CAGR for the next 4 years is 20%.

What is LeMaitre Vascular Inc's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for LeMaitre Vascular Inc's net income is 18%. The projected CAGR for the next 4 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.